Table 1 Clinic-pathological characteristics of the explorative cohort
Ovarian cancer (OC) | Gastrointestinal (GI) cancers | |||
|---|---|---|---|---|
Number of patients | 10 | 8 | ||
Age (years) | 64.6 ± 10.25 | 51.5 ± 18.34 | ||
Gender Ratio (Female/male) | 10/0 (100%) | 7/1 (87.5%) | ||
Histology | High-grade serous carcinoma [n (%)] | 8 (80) | Appendiceal signet ring cell carcinoma | 1 (12.5) |
Low-grade appendiceal mucinous neoplasm | 3 (37.5) | |||
Low-grade serous carcinoma [n (%)] | 1 (10) | Colon adenocarcinoma | 1 (12.5) | |
Clear cell carcinoma [n (%)] | 1 (10) | Gastric adenocarcinoma | 3 (37.5) | |
Federation of gynecology and obstetrics stage (FIGO) | Stage II [n (%)] | 1 (10) | / | |
Stage III [n (%)] | 6 (60) | |||
Stage IV [n (%)] | 3 (30) | |||
T Stage | ||||
T2 [n (%)] | 1 (10) | / | ||
T3 [n (%)] | 7 (70) | 3 (37.5) | ||
T4 [n (%)] | / | 5 (62.5) | ||
Tx [n (%)] | 2 (20) | / | ||
N Stage | ||||
N0 [n (%)] | 4 (40) | 3 (37.5) | ||
N1 [n (%)] | 5 (50) | 1 (12.5) | ||
N2 [n (%)] | / | 2 (25) | ||
N3 [n (%)] | / | 1 (12.5) | ||
Nx [n (%)] | 1 (10) | 1 (12.5) | ||
M Stage | ||||
M0 [n (%)] | 4 (40) | 1 (12.5) | ||
M1 [n (%)] | 2 (20) | 6 (75) | ||
Mx [n (%)] | 4 (40) | 1 (12.5) | ||